Study Stopped
There is no funding to proceed.
Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal is to develop MR imaging techniques to improve delineation of cancer extent, and to improve differential diagnosis between prostate cancer and benign prostate hyperplasia or other benign diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 12, 2008
CompletedFirst Posted
Study publicly available on registry
February 8, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedJuly 20, 2018
July 1, 2018
2 years
January 12, 2008
July 19, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
To demonstrate that multi-voxel MR spectroscopy and diffusion tensor imaging can accurately diagnose prostate cancer and benign diseases, also to provide an accurate disease extent.
at completion of the study
Interventions
MR contrast agent (0.1 mmol/kg)
Eligibility Criteria
You may qualify if:
- A male older than 21 years of age and under age of 80,
- Either a normal healthy volunteer; a patient who has confirmed prostate cancer and decided to receive prostatectomy; or a patient who has persistent elevated PSA higher than 4.0 ng/ml, and with a prior benign biopsy scheduled to receive the second biopsy.
You may not qualify if:
- Unwilling to give informed consent,
- Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices, surgical clips (hemostatic clips) or other metallic implants,
- Have engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or have imbedded metal fragments from military activities,
- Have received orthodontic work involving ferromagnetic materials,
- Claustrophobic,
- Unable to lie down still for 60 minutes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Functional Onco-Imaging, University of California
Irvine, California, 92697, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Min-Ying Su, PhD
University of California, Irvine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 12, 2008
First Posted
February 8, 2008
Study Start
June 1, 2007
Primary Completion
June 1, 2009
Last Updated
July 20, 2018
Record last verified: 2018-07